Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

168 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabeling.
Olafsen T, Bruland OS, Zalutsky MR, Sandlie I. Olafsen T, et al. Nucl Med Biol. 1995 Aug;22(6):765-71. doi: 10.1016/0969-8051(95)00014-o. Nucl Med Biol. 1995. PMID: 8535337
Cancer therapy with radiolabeled antibodies. An overview.
Bruland OS. Bruland OS. Acta Oncol. 1995;34(8):1085-94. doi: 10.3109/02841869509127235. Acta Oncol. 1995. PMID: 8608033 Review.
Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals.
Hassfjell SP, Skretting A, Bruland OS, Hoff P. Hassfjell SP, et al. Nucl Med Commun. 1998 Mar;19(3):207-17. Nucl Med Commun. 1998. PMID: 9625495
Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry.
Aurlien E, Larsen RH, Akabani G, Olsen DR, Zalutsky MR, Bruland OS. Aurlien E, et al. Int J Radiat Biol. 2000 Aug;76(8):1129-41. doi: 10.1080/09553000050111604. Int J Radiat Biol. 2000. PMID: 10947126
168 results
Jump to page
Feedback